FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Teligent Pharma Flurandrenolide Ointment Recall

Flurandrenolide Ointment USP, 0

Teligent Pharma, Inc. · Buena, NJ

Risk level
Class II
Reported by FDA
Apr 28, 2021
Recall ID
D-0356-2021
Check your lot numberHow we source this data

Summary

Teligent Pharma recalled Flurandrenolide Ointment starting Apr 9, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0356-2021 on Apr 28, 2021. Reason: Failed Impurities/Degradation Specifications:. Status: Ongoing.

Why it was recalled

Failed Impurities/Degradation Specifications:

Product description

Flurandrenolide Ointment USP, 0.05%, Net Wt. 60 grams, Rx Only, Teligent Pharma, Inc. Buena, New Jersey 08310 NDC 52565-017-60

Lot numbers, UPCs & expiration codes

Lot #13974 EXP 7/2021

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0356-2021
Classification
Class II
Status
Ongoing
Recall initiated
Apr 9, 2021
FDA report date
Apr 28, 2021
Quantity
3432 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Teligent Pharma, Inc.

Original FDA data

Every field from FDA enforcement report D-0356-2021, exactly as published.

Show all FDA fields
City
Buena
State
NJ
Status
Ongoing
Country
United States
Event ID
87694
Address
105 Lincoln Avenue
Code information
Lot #13974 EXP 7/2021
Postal code
08310
Report date
Apr 28, 2021
Product type
Drugs
Recall number
D-0356-2021
Classification
Class II
Recalling firm
Teligent Pharma, Inc.
Product quantity
3432 tubes
Reason for recall
Failed Impurities/Degradation Specifications:
Voluntary / mandated
Voluntary: Firm initiated
Product description
Flurandrenolide Ointment USP, 0.05%, Net Wt. 60 grams, Rx Only, Teligent Pharma, Inc. Buena, New Jersey 08310 NDC 52565-017-60
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Apr 9, 2021
Initial firm notification
Letter
Center classification date
Apr 28, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0356-2021, published Apr 28, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls